| TITLE: | CLOTTING FACTORS |
| AUTHORS: | RACHID BAZ, MD -- Department of Hematology and Medical Oncology |
| TAREK MEKHAIL, MD -- Department of Hematology and Medical Oncology | |
| REVIEWED: | JULY 15, 2004 |
|
|
||||||||
|
|
||||||||
|
| Table 1: | |||
|
Common
Drugs Causing Platelet Dysfunction
|
|||
|
Interfering
with Platelet Membrane
|
Inhibition
of Prostaglandin Pathways
|
Inhibition
of Platelet Phosphodiesterase
|
Unknown
Mechanism of Action
|
| Amitriptyline | Aspirin | Caffine | Acetazolamide |
| Imipramine | Nonsteroidal Anti-inflammatory drugs |
Dipyridamole | Ethancrynic acid |
| Chlorpromazine | Furosemide | Aminophylline | Hydroxychloroquine |
| Cocaine | Verapamil | Theophylline | Nitroprusside |
| Lidocaine | Hydralazine | Vinblastine | Cyproheptadine |
| Isoproterenol | Cyclosporine A | Vincristine | Nitroglycerin |
| Proranolol | Hydrocortisone | Colchicine | Famotidine |
| Penicillin | Papaverine | Cimetidine | |
| Ampicillin | |||
| Cephalothin | |||
| Promethazine | |||
| Diphenhydramine | |||
| Carbenicillin | |||
|
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this web site. |
|
Copyright
2003 The Cleveland Clinic Foundation
|